Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 GeneticVariation disease BEFREE Mutations in the PARK2 (PRKN) gene are the most common cause of autosomal-recessive (AR) juvenile parkinsonism and young-onset Parkinson's disease (YOPD). 30099245 2018
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 GeneticVariation disease BEFREE Exome sequencing and Sanger sequencing were conducted in the index case diagnosed as juvenile parkinsonism and a homozygous variant, c.850G>C (p.G284R), in the parkin gene was identified. 27177722 2016
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Biomarker disease CTD_human Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. 26558463 2015
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Therapeutic disease CTD_human A recurrent mutation in PARK2 is associated with familial lung cancer. 25640678 2015
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Biomarker disease CTD_human A recurrent mutation in PARK2 is associated with familial lung cancer. 25640678 2015
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Therapeutic disease CTD_human Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. 26558463 2015
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 GeneticVariation disease BEFREE Parkinson protein 2, E3 ubiquitin protein ligase (PARK2) gene mutations are the most frequent causes of autosomal recessive early onset Parkinson's disease and juvenile Parkinson disease. 25136611 2014
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Therapeutic disease CTD_human Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: implication in autosomal recessive juvenile parkinsonism. 23046578 2013
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Biomarker disease BEFREE Parkin, an E3 ubiquitin ligase well known for its role in the pathogenesis of juvenile Parkinson disease, has been considered as a candidate tumor suppressor in certain types of cancer. 23470638 2013
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Biomarker disease CTD_human Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: implication in autosomal recessive juvenile parkinsonism. 23046578 2013
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Biomarker disease GENOMICS_ENGLAND Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. 22956510 2012
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 GeneticVariation disease BEFREE Mutation in PARK2 is also the most common cause of juvenile Parkinson's disease. 20418918 2010
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 GeneticVariation disease BEFREE Parkin gene mutations cause a juvenile parkinsonism. 19672985 2009
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Therapeutic disease CTD_human Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease. 16914382 2006
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Biomarker disease CTD_human Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease. 16914382 2006
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Biomarker disease CTD_human Parkin disease: a phenotypic study of a large case series. 12764051 2003
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Therapeutic disease CTD_human Parkin disease: a phenotypic study of a large case series. 12764051 2003
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 GeneticVariation disease BEFREE Mutations in the PARKIN gene are associated with early-onset (juvenile) Parkinson's disease. 11684352 2001
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Therapeutic disease CTD_human Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. 11254447 2001
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Biomarker disease CTD_human Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. 11254447 2001
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 GeneticVariation disease BEFREE To report the clinical features and results of iodine I 123-2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane (CIT) single photon emission computed tomography and molecular genetic analysis in a Korean woman with juvenile Parkinson disease with deletion in exon 4 of the parkin gene. 11405814 2001
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 GeneticVariation disease BEFREE However, as more than half of patients with JP do not carry a mutation in the 'parkin' gene, more investigations concerning nosological entities should be carried out. 10984665 2000
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Therapeutic disease CTD_human Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. 10894217 2000
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Biomarker disease CTD_human Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. 10894217 2000
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.590 Therapeutic disease CTD_human A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. 10072423 1999